Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/2005
09/21/2005CN1671412A Immunostimulatory compositions and methods of stimulating an immune response
09/21/2005CN1671293A Capture, concentration and quantitation of abnormal prion protein from biological fluids using depth filtration
09/21/2005CN1670206A Protease subunit C7-I of clonorchis sinensis, its coding nucleic acid and application
09/21/2005CN1670205A Protease subunit C3 of clonorchis sinensis, its coding nucleic acid and application
09/21/2005CN1670204A Autolytic enzyme of streptococcus pneumoniae, its coding nucleic acid and application
09/21/2005CN1670202A Microsome GST-1 of clonorchis sinensis, its coding acid and application
09/21/2005CN1670201A Fumaric reductase Ip subunit of liver fluke, its coding acid and application
09/21/2005CN1670200A Lactate dehydrogenase of clonorchis sinensis, its coding nucleic acid and application
09/21/2005CN1670199A I type aldehyde dehydrogenase of clonorchis sinensis, its coding nucleic acid and application
09/21/2005CN1670198A Thermostable type cytoplasm malic dehydrogenase of clonorchis sinensis, its coding nucleic acid and application
09/21/2005CN1670197A Arginase of Japanese blood fluke, its coding nucleic acid and application
09/21/2005CN1670196A Adenylate kinase 3 of clonorchis sinensis, its coding nucleic acid and application
09/21/2005CN1670195A Propionyl-CoA carboxylase of clonorchis sinensis, its coding nucleic acid and application thereof
09/21/2005CN1670194A Calcineurin of clonorchis sinensis, its coding nucleic acid and application
09/21/2005CN1670032A Human telomerase active inhibitor protein and use thereof
09/21/2005CN1219882C Method and combination for treating tumors based on ERBB-3
09/21/2005CN1219796C Application of N-end amino acid of interferon-tau polypeptide
09/21/2005CN1219548C Join of C peptide and insulin for treating diabetes complication and C peptide-specific antibody
09/20/2005US6946547 Via immunoassay; low cross-reactivity with ephedrine and other compounds; antibody produced by a methylene dioxyphenyl derivative of agiven structure
09/20/2005US6946546 Binding ptoren for use in the treatment of asthma, eczema, rhinitis, conjunctivitis, allergies and gastrointestinal disorders
09/20/2005US6946444 Modify the activity of the lipolysis stimulated receptor and can be used to influence the partitioning of dietary lipids between the liver and peripheral tissues; treating obesity-related insulin resistance
09/20/2005US6946438 focal cerebral ischemic infarction; plasmin, mini-plasmin (lacking the first four kringles), and micro-plasmin (lacking all five kringles)
09/20/2005US6946296 Methods and compositions for polypeptide engineering
09/20/2005US6946292 Cells producing antibody compositions with increased antibody dependent cytotoxic activity
09/20/2005US6946289 Single-stranded polynucleotides that code for human melanoma antigen(MAGE) and human leukocyte antigens, used in gene therapy and medical diagnosis; immunology
09/20/2005US6946275 Human testis specific serine/threonine kinase 1 and 2
09/20/2005US6946272 Transition state analogs
09/20/2005US6946264 DNA codes for polypeptides having amino acid sequences used as metalloenzyme inhibitors, for prophylaxis of autoimmune diseases or as wound healing agents
09/20/2005US6946256 Cell regulatory genes, encoded products, and uses related thereto
09/20/2005US6946255 Monoclonal antibody reacting specifically reacting with Fas ligand and production process thereof
09/20/2005US6946247 Mixing drugs and messenger RNA, then hybridizing with ribonuclease protection probes complements and analyzing; immunology; idiotypic antibodies
09/20/2005US6946244 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator
09/20/2005US6946135 Prevention and treatment of amyloidogenic disease
09/20/2005US6946134 improved shelf-life; produced in glycosylation-/protease-free yeast cultures
09/20/2005US6946132 Pure dnaJp1 peptide in a carrier; dnaJ is a heat shock protein; also immunoassay for identifying persons who are predisposed to develop rheumatoid arthritis
09/20/2005US6946131 Comprises heparan sulfate proteoglyeans; antiproliferative agents
09/20/2005US6946130 interleukins (IL-5); for treating conditions associated with excess eosinophil production (such as chronic eosinophilic pneumonia, allergic bronchopulmonary aspergillosis, coeliac disease and/or gastroenteritis)
09/20/2005US6946129 Recombinant anti-CD40 antibody and uses thereof
09/20/2005CA2319703C Growth differentiation factor-8
09/20/2005CA2170606C Type i angiotensin ii receptor specific monoclonal antibodies and hybridomas
09/15/2005WO2005085847A1 Method of detecting allergen
09/15/2005WO2005085464A1 Methods to make and use antibodies of improved cross-reactivity
09/15/2005WO2005085444A1 Chithin oligosaccharide elicitor-binding protein
09/15/2005WO2005085291A1 A kind of fusion protein, gene encoding it, expression method and use thereof
09/15/2005WO2005085290A1 Anti fk778antibodies and high sensitive immunoassay methods
09/15/2005WO2005085289A1 Specific monoclonal and polyclonal antibodies for repinotan and the open ring form thereof
09/15/2005WO2005085288A2 Natural igm antibodies and inhibitors thereof
09/15/2005WO2005084708A1 Medicinal composition containing cxcr3 inhibitor
09/15/2005WO2005084707A1 Method of utilizing organic cation transporter oct3-related molecule for treating mental diseases such as depression, anxiety neurosis, drug addiction and the like
09/15/2005WO2005084329A2 Method for inhibiting tumor formation and growth
09/15/2005WO2005084179A2 Improved method for preparing conjugates of proteins and chelating agents
09/15/2005WO2005084109A2 Cancer specific gene mh15
09/15/2005WO2005058351A3 Treatment of rheumatoid arthritis with soluble fas-ligand cross-linkers
09/15/2005WO2005056759A3 Methods of generating variant proteins with increased host string content and compositions thereof
09/15/2005WO2005052003A3 Use of antibodies to the gamma 2 chain of laminin 5 to inhibit tumor growth and metastasis
09/15/2005WO2005047458A3 Modified recombinant vaccina viruses and other microorganisms, uses thereof
09/15/2005WO2005046711A3 Stimulation or inhibition of gamma delta t-cells to promote or inhibit bone healing
09/15/2005WO2005044855A3 Use of antagonist anti-cd40 monoclonal antibodies for treatment of multiple myeloma
09/15/2005WO2005044306A3 Use of antagonist anti-cd40 antibodies for treatment of autoimmune and inflammatory diseases and organ transplant rejection
09/15/2005WO2005044294A3 Method of therapy for cancers expressing the cd40 antigen
09/15/2005WO2005027966A3 Antibodies with altered effector functions
09/15/2005WO2005026209A3 Monoclonal antibodies against hmgb1
09/15/2005WO2005018536A3 Agonist antibodies that specifically bind the glucagon like peptide-1 receptor
09/15/2005WO2005016232A3 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
09/15/2005WO2005010151A3 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
09/15/2005WO2005007809A3 Antibodies and fusion proteins that include engineered constant regions
09/15/2005WO2005002511A3 Recombinant antibodies and compositions and methods for making and using the same
09/15/2005WO2004089284A3 Targets for tumor growth inhibition
09/15/2005WO2004084823A3 Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof
09/15/2005WO2004083449A3 Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of ovarian cancer
09/15/2005WO2004056307A3 Disease treatment via antimicrobial peptide inhibitors
09/15/2005WO2003095626A3 Purified composition of bispecific molecules and methods of production
09/15/2005WO2003000844A3 Protein modification and maintenance molecules
09/15/2005WO2002048388A3 Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell
09/15/2005US20050204415 Methods of blocking tissue destruction by autoreactive T cells
09/15/2005US20050204414 Methods of blocking tissue destruction by autoreactive T cells
09/15/2005US20050204413 Methods of blocking tissue destruction by autoreactive T cells
09/15/2005US20050204412 Artery- and vein-specific proteins and uses therefor
09/15/2005US20050203048 Human leucine-rich repeat containing protein expressed predominately in bone marrow, HLRRBM1
09/15/2005US20050203046 Modulating immune disorder or condition by administering an effective amount of an agonist or antagonist of IL-33 or IL-33 Receptor complex (IL-33R); modulates response to a number of immune and inflammatory conditions such as asthma, allergy, multiple sclerosis, inflammatory bowel disorder, arthritis
09/15/2005US20050202548 Mammalian enzymatic polypeptide for use as tool in designing drugs which prevent and treat hypercholesterolemia, hyperlipemia, arteriosclerosis, parasitic infection, cell proliferative and vascular diseases
09/15/2005US20050202534 Molecularly engineered binding domain-immunoglobulin fusion proteins, including single chain Fv-immunoglobulin fusion protein useful for treating malignant conditions and B-cell disorders, such as disease caused by autoantibody production
09/15/2005US20050202531 Receptor protein for identifying modulators to treat and prevent inflammatory, antherosclerotic and cancer disorders; wound healing agents
09/15/2005US20050202529 Humanised antibodies
09/15/2005US20050202526 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/15/2005US20050202517 Monoclonal antibodies against human apoptosis inhibitory protein NAIP and method for assaying the NAIP
09/15/2005US20050202516 Methods and compositions for neural progenitor cells
09/15/2005US20050202512 Immunoglobulins; libraries; antibodies; complementary determining regions; immunoassay
09/15/2005US20050202506 Immunoglobulin for use in prevention and treatment of bone, glandular and kidney disorders; immunotherapy
09/15/2005US20050202503 Displacement assay for detection of small molecules
09/15/2005US20050202499 Reagents and methods useful for detecting diseases of the breast
09/15/2005US20050202496 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/15/2005US20050202482 CD38 splice variants and uses thereof
09/15/2005US20050202481 Novel polypeptide ESDN, polynuleotides encoding the polypeptide, and utility of the polypeptide
09/15/2005US20050202474 Phosphodiesterases
09/15/2005US20050202467 Nucleotide sequences coding serotonin receptor (5-HT1A receptor) for use in identifying modulators for prevntion and treatment of neuropsychiatric disorders
09/15/2005US20050202454 "STRAP" and "STEAP"(six transmembrane (epithelial) antigen of the prostate)
09/15/2005US20050202452 Assay determining the activity of an agent to decrease cell division; contacting protein capable of superoxide production with compound of interest and and measuring the ability of the agent to decrease superoxide production, inhibit diaphorase activity or bind the protein
09/15/2005US20050202430 Nucleotide sequences coding extracellular matrix protein for use in treatment and prevention of cell proliferative disorders; promoting osteogenesis
09/15/2005US20050202418 HCV peptide compositions
1 ... 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 ... 1494